|
⚲
|
| Keyboard |
| Patton John Stuart
✚
|
|
|---|---|
| CIK # | 0001247653 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001247653] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Patton John Stuart | |
| Halozyme Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2014-08-19 | Sell | 75,000 | $9.96 | 747,000 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2014-08-19 | Option exercise | 75,000 | $2.05 | 153,750 |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2014-08-19 | Option exercise | 75,000 | $2.05 | 153,750 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2014-05-13 | Grant | 24,876 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2013-09-16 | Sell | 37,500 | $9.16 | 343,500 |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock (NSO) · derivative
|
2013-09-13 | Option exercise | 100,000 | $0.39 | 39,000 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2013-09-13 | Option exercise | 100,000 | $0.39 | 39,000 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2013-09-13 | Sell | 37,500 | $9.10 | 341,250 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2013-05-16 | Grant | 20,000 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2012-05-03 | Grant | 20,000 | $0.00 |